搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haemophilus influenzae UPF0260 protein HI_1355 (HI_1355) CSB-YP332117HTA
CSB-EP332117HTA
CSB-BP332117HTA
CSB-MP332117HTA
CSB-EP332117HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1376 (HI_1376), partial CSB-YP332118HTA
CSB-EP332118HTA
CSB-BP332118HTA
CSB-MP332118HTA
CSB-EP332118HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae UPF0267 protein HI_1394 (HI_1394) CSB-YP332119HTA
CSB-EP332119HTA
CSB-BP332119HTA
CSB-MP332119HTA
CSB-EP332119HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1396 (HI_1396) CSB-YP332120HTA
CSB-EP332120HTA
CSB-BP332120HTA
CSB-MP332120HTA
CSB-EP332120HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1402 (HI_1402) CSB-YP332121HTA
CSB-EP332121HTA
CSB-BP332121HTA
CSB-MP332121HTA
CSB-EP332121HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1404 (HI_1404) CSB-YP332122HTA
CSB-EP332122HTA
CSB-BP332122HTA
CSB-MP332122HTA
CSB-EP332122HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1406 (HI_1406) CSB-YP332123HTA
CSB-EP332123HTA
CSB-BP332123HTA
CSB-MP332123HTA
CSB-EP332123HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1409 (HI_1409) CSB-YP332124HTA
CSB-EP332124HTA
CSB-BP332124HTA
CSB-MP332124HTA
CSB-EP332124HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1413 (HI_1413), partial CSB-YP332125HTA1
CSB-EP332125HTA1
CSB-BP332125HTA1
CSB-MP332125HTA1
CSB-EP332125HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1415 (HI_1415) CSB-YP332126HTA
CSB-EP332126HTA
CSB-BP332126HTA
CSB-MP332126HTA
CSB-EP332126HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1418 (HI_1418) CSB-YP332127HTA
CSB-EP332127HTA
CSB-BP332127HTA
CSB-MP332127HTA
CSB-EP332127HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1420 (HI_1420) CSB-YP332128HTA
CSB-EP332128HTA
CSB-BP332128HTA
CSB-MP332128HTA
CSB-EP332128HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1422 (HI_1422) CSB-YP332129HTA
CSB-EP332129HTA
CSB-BP332129HTA
CSB-MP332129HTA
CSB-EP332129HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1427 (HI_1427) CSB-YP332130HTA
CSB-EP332130HTA
CSB-BP332130HTA
CSB-MP332130HTA
CSB-EP332130HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae UPF0745 protein HI_1446 (HI_1446) CSB-YP332131HTA
CSB-EP332131HTA
CSB-BP332131HTA
CSB-MP332131HTA
CSB-EP332131HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1452 (HI_1452), partial CSB-YP332132HTA1
CSB-EP332132HTA1
CSB-BP332132HTA1
CSB-MP332132HTA1
CSB-EP332132HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1456 (HI_1456), partial CSB-YP332133HTA1
CSB-EP332133HTA1
CSB-BP332133HTA1
CSB-MP332133HTA1
CSB-EP332133HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1469 (HI_1469) CSB-YP332134HTA
CSB-EP332134HTA
CSB-BP332134HTA
CSB-MP332134HTA
CSB-EP332134HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized HTH-type transcriptional regulator HI_1476 (HI_1476) CSB-YP332135HTA
CSB-EP332135HTA
CSB-BP332135HTA
CSB-MP332135HTA
CSB-EP332135HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1479 (HI_1479) CSB-YP332136HTA
CSB-EP332136HTA
CSB-BP332136HTA
CSB-MP332136HTA
CSB-EP332136HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>